ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
Methodology & AI Transparency ⓘ
ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery is an ICD-10-CM indexed diagnosis (I21.02) within Heart & Cardiovascular Disease.
- 2 Real-world patient consensus: Mapped to Heart & Cardiovascular Disease under ICD-10-CM I21.02 for ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery clinical workups.
- 3 Typical cash cost range: Clinicians assessing ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery focus on electrical conduction pathway in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (I21.02: remodeling) and targeted history.
- 4 Top reported side effects / signs: Follow-up benchmark in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery: maintaining Apolipoprotein B (ApoB) [ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.02] within < 70 mg/dL (I21.02).
Ask our AI Specialists anything about ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
What Is ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery?
ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery is an ICD-10-CM indexed diagnosis (I21.02) within Heart & Cardiovascular Disease. Clinical evaluation centers on cardiopulmonary biomarker stratification [ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.02] alongside serial Apolipoprotein B (ApoB) [ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.02] tracking (< 70 mg/dL (I21.02)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (I21.02) features electrical conduction pathway in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (I21.02: remodeling). therapeutic stabilization in heart & vascular is verified against Left Ventricular Ejection in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (I21.02: Fraction (LVEF)).
Common Symptoms & Clinical Signs
- • Presentation of ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (I21.02): exertional chest pressure in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (I21.02: or retrosternal tightness)
- • Secondary ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery clinical sign: shortness of breath in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (I21.02: when climbing stairs)
- • Symptom flares in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery correlating with Apolipoprotein B (ApoB) [ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.02] deviation outside < 70 mg/dL (I21.02)
- • Functional heart & vascular impact requiring cardiopulmonary biomarker stratification [ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.02] evaluation (I21.02)
ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I21.02 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Heart & Cardiovascular Disease | NLM Clinical Tables |
| Diagnostic / Lab Marker: Apolipoprotein B (ApoB) [ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.02] | < 70 mg/dL (I21.02) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Left Ventricular Ejection in ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery (I21.02: Fraction (LVEF)) | 55% – 70% (I21.02) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: NT-proBNP [ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery I21.02] | < 100 pg/mL (I21.02) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Midodrine Hydrochloride ProAmatine • RxCUI 993462 | alpha-Adrenergic Agonist | 87% | $0.0737 | $ 5.90 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Liraglutide on no-reflow in patients with acute ST-segment elevation heart: What a 284-Participant Study Found Liraglutide may be associated with less no-reflow in STEMI, which should be confirmed by larger-scale trials. International journal of cardiology • 2016-04-01 • Randomized Controlled Trial | N = 284 | 93/100 | PMID 26849684 ↗ |
| Can This Approach Help? Inside the Latest Research on Reduction in the magnitude of serum potassium elevation in combination therapy In Japanese patients with type 2 diabetes and albuminuria treated with esaxerenone, concomitant use of SGLT2 inhibitor reduced the magnitude of serum potassium elevation without any change of its blood-pressure-lowering and... Journal of diabetes investigation • 2022-07-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 35199478 ↗ |
| Can This Approach Help? Inside the Latest Research on Assessing the potential correlation of polymorphisms in the IL6R with relative While it is unlikely that "cytokine storm" is the norm in severe COVID19, baseline elevations above 150 pg/ml may be associated with worst outcomes and as such may warrant treatment considerations. Cytokine • 2021-12-15 • Phase III Randomized Trial | N = 100 | 88/100 | PMID 34353696 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefit and tolerability of the getting both at the same time of ezetimibe and Ezetimibe combination with low dose statin in patients in acute coronary syndrome could be a safe, potent therapy to reduce LDL level with antiinflammatory effect. Le Journal medical libanais. The Lebanese medical journal • 2011-01-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 21834489 ↗ |
| Can This Approach Help? Inside the Latest Research on Different doses of atorvastatin, rosuvastatin, and simvastatin on older adults Patients with higher doses had lower level of CK-MB, BNP, ALT, and TnI and lower occurrence of MACE after PCI. Drug development research • 2020-08-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 32142170 ↗ |
ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery Patient Community & “People Like Me” Threads
Filter ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery community threads and patient logs by age, biological sex, dosage, and treatment duration.